Incyte Corp at Cowen Healthcare Conference (Virtual) Transcript
Hello. Welcome back to the Cowen Healthcare Conference. Next session is a fireside chat with Incyte. And we're really pleased to have with us CEO, Herve Hoppenot; CMO, Steven Stein; and CFO, Christiana Stamoulis. We will get to Q&A, and we do encourage the audience to participate. (Operator Instructions)
But we'll start off with -- everybody is going to make a few kind of general overview comments, give a status update, and then we will get into specific questions. So Herve?
Yes. Okay. Thank you, Marc. I'll be very quick. I just will show 2 slides. One is about 2020. So you have it in front of you. And what you can see is basically, it was a year where we had 3 products approved by FDA. So it's Monjuvi, it's Pemazyre, it's Tabrecta. So it was an important year of diversification, and obviously, of growth. The top line, the revenue grew at 24% including milestone, 18% without the milestone. So the sort of run rate
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
